Close Menu

NEW YORK (GenomeWeb) – Invitae announced today that it has acquired privately owned data company AltaVoice. Under the terms of the deal, Invitae purchased all of AltaVoice's stock in exchange for $5 million in Invitae common stock and up to an additional $10 million in Invitae common stock if certain future milestones are met.

The acquisition will add to Invitae's Genome Network, the company said, which connects patients, clinicians, advocacy organizations, researchers, and pharma companies to advance the understanding of hereditary disease and its possible treatments.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.